Abstract
Esophageal cancer (EC) is the seventh most common cancer, with a poor prognosis for metastatic EC patients and limited effective drugs for treatment. Nivolumab and pembrolizumab, monoclonal antibod...
Funding Information
  • ONO Pharmaceuticals and MSD

This publication has 44 references indexed in Scilit: